PREMIUM: A French prospective multicenter observational study of factors impacting on efficacy and compliance to cetuximab treatment in first-line KRAS wild-type metastatic colorec...

por Mineur, L., François, E., Plassot, C., Phelip, J. M., Miglianico, L., Dourthe, L. M., Bonichon, N., Moreau, L., Guimbaud, R., Smith, D., Achille, E., Hervé, R., Bons, J. M., Remy, S., Faroux, R., Villing, A. L., Mahamat, A., Rabbia, I., Soulié, P., Baumgaertner, I., Mathé, N., Vazquez, L., Boustany, R.
Publicado 2020

Colorectal cancer (CRC) monitoring by 6-monthly (18)FDG-PET/CT: an open-label multicentre randomised trial

por Sobhani, I, Itti, E, Luciani, A, Baumgaertner, I, Layese, R, André, T, Ducreux, M, Gornet, J -M, Goujon, G, Aparicio, T, Taieb, J, Bachet, J -B, Hemery, F, Retbi, A, Mons, M, Flicoteaux, R, Rhein, B, Baron, S, Cherrak, I, Rufat, P, Le Corvoisier, P, de’Angelis, N, Natella, P -A, Maoulida, H, Tournigand, C, Durand Zaleski, I, Bastuji-Garin, S
Publicado 2018